KR101497003B1 - 인산염 흡착제 - Google Patents

인산염 흡착제 Download PDF

Info

Publication number
KR101497003B1
KR101497003B1 KR20117023162A KR20117023162A KR101497003B1 KR 101497003 B1 KR101497003 B1 KR 101497003B1 KR 20117023162 A KR20117023162 A KR 20117023162A KR 20117023162 A KR20117023162 A KR 20117023162A KR 101497003 B1 KR101497003 B1 KR 101497003B1
Authority
KR
South Korea
Prior art keywords
composition
delete delete
iron
calcium
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR20117023162A
Other languages
English (en)
Korean (ko)
Other versions
KR20110128329A (ko
Inventor
기셀라 위첼
피터 가이서
에리크 필립
Original Assignee
비포르 (인터내셔날) 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101497003(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 비포르 (인터내셔날) 아게 filed Critical 비포르 (인터내셔날) 아게
Publication of KR20110128329A publication Critical patent/KR20110128329A/ko
Application granted granted Critical
Publication of KR101497003B1 publication Critical patent/KR101497003B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR20117023162A 2009-03-02 2010-03-01 인산염 흡착제 Expired - Fee Related KR101497003B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09154107 2009-03-02
EP09154107.8 2009-03-02
PCT/EP2010/052551 WO2010100112A1 (en) 2009-03-02 2010-03-01 Phosphate adsorbent

Publications (2)

Publication Number Publication Date
KR20110128329A KR20110128329A (ko) 2011-11-29
KR101497003B1 true KR101497003B1 (ko) 2015-02-27

Family

ID=40627528

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20117023162A Expired - Fee Related KR101497003B1 (ko) 2009-03-02 2010-03-01 인산염 흡착제

Country Status (20)

Country Link
US (1) US20120052135A1 (enExample)
EP (1) EP2403506A1 (enExample)
JP (1) JP2012519201A (enExample)
KR (1) KR101497003B1 (enExample)
CN (1) CN102341111A (enExample)
AR (1) AR076070A1 (enExample)
AU (1) AU2010220396B2 (enExample)
BR (1) BRPI1009110A2 (enExample)
CA (1) CA2753364A1 (enExample)
CL (1) CL2011002130A1 (enExample)
IL (1) IL214509A0 (enExample)
MX (1) MX2011009144A (enExample)
MY (1) MY162484A (enExample)
NZ (1) NZ594730A (enExample)
PE (1) PE20120327A1 (enExample)
RU (1) RU2527682C2 (enExample)
SG (1) SG173887A1 (enExample)
TW (1) TWI454267B (enExample)
WO (1) WO2010100112A1 (enExample)
ZA (1) ZA201106305B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
EP2548562A1 (de) 2011-07-18 2013-01-23 SeBo GmbH Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern
CN105007759B (zh) * 2013-03-08 2018-11-20 上海礼邦医药科技有限公司 金属离子-功能性纤维组分络合物组合物、其制备及用途
EP2805603B1 (de) * 2013-05-22 2017-01-11 CLAAS E-Systems KGaA mbH & Co KG Vorrichtung und Verfahren zur Überwachung der Schneidenschärfe
WO2015181205A1 (en) 2014-05-28 2015-12-03 Biaqua B.V. Method for removing phosphate from water fractions
CN105232767A (zh) * 2015-09-29 2016-01-13 江苏锦宇环境工程有限公司 一种制备吸附磷酸盐的药物制剂的方法
CN107397758A (zh) * 2016-05-19 2017-11-28 欣凯医药化工中间体（上海）有限公司 一种磷结合剂及其制备方法
CN107397760B (zh) * 2016-05-19 2021-07-30 欣凯医药化工中间体（上海）有限公司 基于铁的氢氧化物－低分子量糖的磷结合剂、其制备方法及其应用
EP3631472B1 (en) 2017-05-31 2022-07-13 Mars, Incorporated Methods of diagnosing and treating chronic kidney disease
SI3930686T1 (sl) 2019-02-28 2023-11-30 Renibus Therapeutics, Inc. Novi železovi sestavki ter metode njihove izdelave in uporabe
US20210130251A1 (en) * 2019-07-17 2021-05-06 Water Warriors Inc. Adsorbent Structures for the Removal of Phosphates and Ammonia from Wastewater and Methods of Use
CN114126402A (zh) * 2019-07-23 2022-03-01 雀巢产品有限公司 具有针对猫科动物的肾脏有益效果的方法和组合物
CN113029978A (zh) * 2019-12-25 2021-06-25 远大生命科学(辽宁)有限公司 一种检测含镧试剂的磷结合能力的方法
CN111905736B (zh) * 2020-07-23 2021-10-26 安徽工业大学 一种半胱氨酸功能化改性的羟基氧化铁、电催化剂、制备方法及应用
WO2025176793A1 (en) * 2024-02-21 2025-08-28 Mars, Incorporated Food composition for treating mineral bone disorder

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010030624A (ko) * 1997-09-19 2001-04-16 로드니 브이 테이트 인산염 결합제로서의 혼합 또는 황산화된 금속 화합물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
DE19547356A1 (de) * 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
DE19917705C1 (de) * 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
EP2918548A1 (en) * 2006-12-14 2015-09-16 Novartis Tiergesundheit AG Iron(iii) sugar based phosphate adsorbent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010030624A (ko) * 1997-09-19 2001-04-16 로드니 브이 테이트 인산염 결합제로서의 혼합 또는 황산화된 금속 화합물

Also Published As

Publication number Publication date
RU2011140017A (ru) 2013-04-10
RU2527682C2 (ru) 2014-09-10
MY162484A (en) 2017-06-15
MX2011009144A (es) 2011-09-15
TWI454267B (zh) 2014-10-01
IL214509A0 (en) 2011-09-27
AR076070A1 (es) 2011-05-18
US20120052135A1 (en) 2012-03-01
ZA201106305B (en) 2012-05-30
JP2012519201A (ja) 2012-08-23
WO2010100112A1 (en) 2010-09-10
TW201034677A (en) 2010-10-01
CN102341111A (zh) 2012-02-01
CL2011002130A1 (es) 2012-03-23
CA2753364A1 (en) 2010-09-10
BRPI1009110A2 (pt) 2019-09-24
AU2010220396A1 (en) 2011-09-01
AU2010220396B2 (en) 2013-10-17
KR20110128329A (ko) 2011-11-29
EP2403506A1 (en) 2012-01-11
NZ594730A (en) 2013-06-28
SG173887A1 (en) 2011-10-28
PE20120327A1 (es) 2012-04-11

Similar Documents

Publication Publication Date Title
KR101497003B1 (ko) 인산염 흡착제
Trailokya et al. Calcium and calcium salts
US8728533B2 (en) Composition comprising crustacean gastrolith components and its use
US6287607B2 (en) Potassium calcium citrate compositions and methods therefor
US8216614B2 (en) Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
EP2338495A1 (en) Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease
US20110098347A1 (en) Phosphorous binder for treatment of kidney disease
CA2624619C (en) Improved toleration iron supplement compositions
CN101129351A (zh) 一种补铁剂组合物,其制备方法和应用
WO2008116215A2 (en) Phosphorus binder for treatment of renal disease
Funk et al. Interactions Between Iron (III)-hydroxide Polymaltose Complex and Commonly Used Medications
US20040048925A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040220266A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
KR20200083971A (ko) 칼슘 보충용 조성물
WO2005096846A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20090239914A1 (en) Phosphorus binder for treatment of renal disease
KR20120066918A (ko) 골다공증 예방 효과를 가지는 유기태화 칼슘 강화 유단백질

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0701 Decision of registration after re-examination

St.27 status event code: A-3-4-F10-F13-rex-PX0701

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180224

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180224

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000